JP2017524682A5 - - Google Patents

Download PDF

Info

Publication number
JP2017524682A5
JP2017524682A5 JP2016575363A JP2016575363A JP2017524682A5 JP 2017524682 A5 JP2017524682 A5 JP 2017524682A5 JP 2016575363 A JP2016575363 A JP 2016575363A JP 2016575363 A JP2016575363 A JP 2016575363A JP 2017524682 A5 JP2017524682 A5 JP 2017524682A5
Authority
JP
Japan
Prior art keywords
concentration
pharmaceutical composition
antigen
cpg
aluminum adjuvant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016575363A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017524682A (ja
Filing date
Publication date
Priority claimed from CN201410294142.3A external-priority patent/CN105214083A/zh
Application filed filed Critical
Publication of JP2017524682A publication Critical patent/JP2017524682A/ja
Publication of JP2017524682A5 publication Critical patent/JP2017524682A5/ja
Pending legal-status Critical Current

Links

JP2016575363A 2014-06-26 2015-06-12 ＣｐＧオリゴヌクレオチドを含む医薬組成物 Pending JP2017524682A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201410294142.3 2014-06-26
CN201410294142.3A CN105214083A (zh) 2014-06-26 2014-06-26 含有CpG寡核苷酸的药物组合物
PCT/CN2015/081330 WO2015196935A1 (zh) 2014-06-26 2015-06-12 含有CpG寡核苷酸的药物组合物

Publications (2)

Publication Number Publication Date
JP2017524682A JP2017524682A (ja) 2017-08-31
JP2017524682A5 true JP2017524682A5 (enExample) 2018-07-26

Family

ID=54936744

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016575363A Pending JP2017524682A (ja) 2014-06-26 2015-06-12 ＣｐＧオリゴヌクレオチドを含む医薬組成物

Country Status (5)

Country Link
US (1) US10052378B2 (enExample)
EP (1) EP3162379A4 (enExample)
JP (1) JP2017524682A (enExample)
CN (1) CN105214083A (enExample)
WO (1) WO2015196935A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3630175A4 (en) 2017-05-31 2021-03-17 Texas Tech University System METHOD AND DEVICE FOR TREATMENT OF FOOD ALLERGIES
CN107987159B (zh) * 2017-11-28 2021-06-22 上海药明生物医药有限公司 一种使用大剂量dna免疫技术免疫动物使血清中抗体滴度提高的方法
JP7385206B2 (ja) * 2018-12-04 2023-11-22 国立大学法人大阪大学 免疫賦活剤
CN112007149A (zh) * 2019-05-29 2020-12-01 思格(苏州)生物科技有限公司 一种新型复合免疫佐剂及其应用
CN115177724A (zh) * 2019-06-28 2022-10-14 怡道生物科技(苏州)有限公司 一种重组带状疱疹疫苗组合物及其用途
CN113493790A (zh) * 2020-04-01 2021-10-12 南京华普生物技术股份有限公司 具有免疫调节功能的CpG ODN及其应用
CN113521273A (zh) * 2020-04-17 2021-10-22 北京科兴中维生物技术有限公司 一种使用含有CpG寡聚脱氧核苷酸的复合佐剂的新冠COVID-19灭活疫苗
WO2021249116A1 (en) 2020-06-10 2021-12-16 Sichuan Clover Biopharmaceuticals, Inc. Coronavirus vaccine compositions, methods, and uses thereof
CA3202133A1 (en) * 2020-12-16 2022-06-23 Martin Gohlke Method for quantifying cpg-containing oligonucleotides in formulations comprising alum
CN115120713A (zh) * 2021-03-25 2022-09-30 四川大学 氢氧化铝-CpG寡核苷酸-多肽复合佐剂、疫苗及制备方法和用途
CN113304257A (zh) * 2021-04-15 2021-08-27 浙江天元生物药业有限公司 一种双佐剂新型冠状病毒灭活疫苗的制备方法及应用
CN115252772A (zh) * 2021-04-30 2022-11-01 华普生物技术(江苏)股份有限公司 人工合成的含CpG单链脱氧寡核苷酸在疫苗中的应用
CN113797329A (zh) * 2021-10-19 2021-12-17 启锰生物科技(江苏)有限公司 一种二价锰佐剂和CpG佐剂的疫苗佐剂组合物及其制作方法
CN117653724A (zh) 2022-09-07 2024-03-08 远大赛威信生命科学(南京)有限公司 一种用于预防乙型肝炎病毒感染的药物组合物及其应用
CN117448337B (zh) * 2023-09-15 2025-11-28 安徽智飞龙科马生物制药有限公司 CpG寡聚脱氧核苷酸、包含其的佐剂、疫苗及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080003232A1 (en) * 2004-11-29 2008-01-03 Liying Wang Cpg Single Strand Deoxynucleotides for Use as Adjuvant
US20120251572A1 (en) * 2009-09-30 2012-10-04 Takaji Wakita Hepatitis c virus vaccine composition

Similar Documents

Publication Publication Date Title
JP2017524682A5 (enExample)
JP2012136541A5 (enExample)
JP2016531144A5 (enExample)
JP2009539965A5 (enExample)
JP2016539946A5 (enExample)
HRP20221263T1 (hr) Ciklički di-nukleotidni spojevi i postupci uporabe
JP2019531293A5 (enExample)
JP2016506416A5 (enExample)
JP2011518170A5 (enExample)
JP2017523180A5 (enExample)
JP2012531420A5 (enExample)
JP2013241424A5 (enExample)
JP2013518107A5 (enExample)
JP2016501828A5 (enExample)
JP2016508999A5 (enExample)
RU2017137357A (ru) Быстрорастворяющаяся лекарственная форма пероральной вакцины, в которой используют крахмал
JP2020097577A5 (enExample)
JP2015533376A5 (enExample)
JP2011528897A5 (enExample)
HRP20211749T1 (hr) Pentanske kiseline supstituirane pirolo-[2-3,b]pirimidin-piridinima za liječenje virusnih infekcija influencom
JP2016539157A5 (enExample)
JP2018522028A5 (enExample)
ES2351489T3 (es) Vacunas mejoradas.
JP2015524802A5 (enExample)
JP2010506926A5 (enExample)